technology development

Sentieon will integrate its DNAseq and TNseq variant-calling technology into Qiagen's CLC Genomics Workbench and the Qiagen Clinical Insight platform.

Genome Canada and its partners recently funded two new initiatives with C$255 that will back precision medicine, genomics, and technology development.

Datavant, a fledgling spinoff from Roivant Sciences, is trying to break down information silos that often lead to poorly designed clinical trials.

Google expects its newly released open-source update to DeepVariant to improve the accuracy of variant calling, particularly in plant and animal genomes.

In healthcare, Cloudera has evolved from mostly supporting downstream variant stores to being a centerpiece of the shift to GATK4.

Fresh out of Techstars, two of the creators of the rapidly adopted genomic analysis platform Nextflow have big plans for their fledgling company, Lifebit.

After more than two years of development, the British vendor has matched HPC for sequencing alignment accuracy, at far lower power consumption.